Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Hindustan Copper Ltd
NSE:HINDCOPPER
|
IN |
|
B
|
BioNxt Solutions Inc
CNSX:BNXT
|
CA |
|
W
|
Wynn Resorts Ltd
XHAM:WYR
|
US |
|
G
|
Gander Gold Corp
OTC:GANDF
|
CA |
|
Pacific Metals Co Ltd
TSE:5541
|
JP |
|
A
|
Abercrombie & Fitch Co
LSE:0R32
|
US |
|
S
|
Shenzhen Heungkong Holding Co Ltd
SSE:600162
|
CN |
|
Tambovskaya Energosbytovaya Kompaniya PAO
MOEX:TASB
|
RU |
|
Adamas One Corp
OTC:JEWL
|
US |
Cumberland Pharmaceuticals Inc
Other Items
Cumberland Pharmaceuticals Inc
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
|
Other Items
-$4.5m
|
CAGR 3-Years
27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Items
-$18.8B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-16%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Items
-$2.8B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
23%
|
CAGR 10-Years
-14%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Items
$1.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Items
-$9.6B
|
CAGR 3-Years
-156%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-11%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Items
-$123m
|
CAGR 3-Years
46%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Cumberland Pharmaceuticals Inc
Glance View
Cumberland Pharmaceuticals, Inc. is a specialty pharmaceutical company, which engages in the acquisition, development, and commercialization of prescription products. The company is headquartered in Nashville, Tennessee and currently employs 83 full-time employees. The company went IPO on 2009-08-11. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever; Kristalose for oral solution, a prescription laxative, for the treatment of constipation; and Omeclamox-Pak for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease. Its brands also include RediTrex injection, for the treatment of active rheumatoid, juvenile idiopathic and severe psoriatic arthritis, as well as disabling psoriasis; Sancuso transdermal system, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and Vibativ injection.
See Also
What is Cumberland Pharmaceuticals Inc's Other Items?
Other Items
-4.5m
USD
Based on the financial report for Dec 31, 2025, Cumberland Pharmaceuticals Inc's Other Items amounts to -4.5m USD.
What is Cumberland Pharmaceuticals Inc's Other Items growth rate?
Other Items CAGR 3Y
27%
The average annual Other Items growth rates for Cumberland Pharmaceuticals Inc have been 27% over the past three years .
